Preliminary Program.

 
 
  Chair: PROF ALAN LOPEZ, The University of Melbourne

8:00AM DR PEDRO ALONSO, Director, Global Malaria Programme, World Health Organisation
Malaria today

8:30AM PROF SIMON HAY, Washington University & Institute for Health Metrics and Evaluation
The numbers

9:15AM PLENARY

9:40AM DR OANH KHUAT THI HAI, Director, Vietnam
Community perspective on malaria elimination

10:00AM MORNING TEA & NETWORKING

  Chair: JANE HALTON, CEPI

10:30AM PROF DAVID HEYMANN, CBE, Head, Centre for Global Health Security, Chatham House
How Eradication and Elimination programmes contribute to Global Health Security

10:45AM DR JIMMIE RODGERS, Director-General, Secretariat of the Pacific


11:30AM PANEL DISCUSSION,

12:00PM PLENARY 


12:30PM LUNCH & NETWORKING

1:30PM CONCURRENT 1
  The malaria map & current challenges & Peoples engagement in malaria programmes Malaria Elimination: Whose business is it & Scale-up & innovating with existing interventions Elimination of malaria from Asia Pacific - Plasmodium vivax & knowlesi Immunity in an elimination contextScience informing R&D for elimination
  Chairs: Prof Graham Brown, The University of Melbourne & Dr Tenneth Dalipanda, Secretary of Health, Solomon Islands

Chairs: Jane Halton, Coalition for Epidemic Preparedness Innovations & Dr Philip Welkhoff, Malaria Program Director, Bill & Melinda Gates Foundation Chairs: Dr Jetsumon Prachumsri, Mahidol University & Prof Karen Day, University of Melbourne

Chairs: Prof Kevin Marsh, African Academy of Science & University of OxfordProfessor Vicky Avery, Griffith University
  Prof Alan Lopez AC, University of Melbourne

Panel Discussion
Dr Winnie Mpanju-Shumbusho, Chair, RBM Partnerships
Lelio Marmora, Executive Director, UNITAID
Dr David Reddy, CEO, Medicines for Malaria Venture


Dr Jetsumon Prachumsri, Mahidol University

Dr Faith Osier, Principal Investigator Kenya Medical Research Institute (KEMRI)/Wellcome Trust
Correlates of Protection from Multi-Centre Cohort Studies in Africa
  Prof Lisa White, Oxford University


Dr Philip Welkhoff, Malaria Program Director, Bill & Melinda Gates Foundation

Prof Ivo Mueller, Walter Eliza Hall Institute/Pasteur Institute

Prof Denise Doolan, James Cook University
  Associate Prof Caroline Buckee, Harvard School of Public Health Dr Scott Filler, Senior Disease Coordinator, Malaria, Global Fund
Effective malaria frontline approaches

Prof Dennis Shanks, Army Malaria Institute

Prof Kevin Marsh, Oxford University
Implications for population immunity & the hidden benefits of malaria elimination
  Professor Maxine Whittaker, James Cook University
What have we learnt about community involvement from control to elimination of malaria

Dr Kimberley A. Lindblade, Global Malaria Program, World Health Organisation

Mayfong Mayxay (Australian Award Fellowship), University of Health Sciences, Lao PDR 

Prof Georges Grau, University of Sydney
How can immunopathology and immunomodulation help malaria eradication?
  George Taleo, Director General, Ministry of Health, Vanuatu
Lessons from the Pacific – Vanuatu

Dr Justin Cohen, Senior Director for Global Malaria, Clinton Health Access Initiative
CHAI work in Haiti/Swaziland/Namibia
Prof Gao Qi, Jiangsu Institute of Parasitic Diseases, China
Malaria elimination in China

Prof Vicky Avery, Griffith University
  Albino Bobogare, Vector Borne Disease Control Program, Ministry of Health Solomon Islands
Lessons learnt from Solomon Islands

  Dr Sarah Auburn, Menzies School of Health Research
Molecular surveillance to inform elimination strategies

Prof Celia Garcia, University of Sao Paolo Brazil
  Dr Paison Dakulala, Deputy Secretary of Health, Papua New Guinea
PNG: Working with communities for elimination
  Professor Nick Anstey, Menzies School of Health Research

Prof Kiaran Kirk, Australian National University
  Edgar Pollard, James Cook University
Where are people located when mosquitoes are biting in Solomon Islands

  Dr Angela Devine, Menzies School of Health Research
Economic costs of P. vivax episodes: a multi-country comparative analysis using primary trial data
Dr Patricia Graves
Low dose primaquine for reducing Plasmodium falciparum transmission: systematic review and meta-analysis
  Lisa Davidson, Burnet Institute
Empowering communities in East New Britain, PNG to eliminate Plasmodium falciparum malaria

 

 
  Q&A Panel

 

 
3:30PM AFTERNOON TEA& NETWORKING

4:00PM CONCURRENT 2
  Residual malaria transmission & Mass drug administration for elimination Maintaining national political leadership in the context of declining infection rates & Resurgence & containing artemisinin resistance Context & community participation: what have we learnt &  The role of advocacy in communications in malaria elimination Radical Cures of Malaria - Trials and Tribulations
  Chairs: Dr Gerry Killeen, Liverpool School of Tropical Medicine & Prof Arjen Dondorp, Mahidol University

Chair: Sir Hon Dr Puka Temu, Minister of Health, Papua New Guinea

Chairs: Prof Ric Price, Menzies School of Health Research

  Dr Tanya Russell, James Cook University
Effective Malaria Control of €œOutdoor-Biting€ Vectors with an Indoor Intervention

Hon. Dr Rajitha Senaratne, Minister of Health, Sri Lanka


Panel Discussion: How does context affect participation? APMEN perspectives Facilitator: Effie Espino

Prof Ric Price, Menzies School of Health Reseach

  Dr Moses Laman, PNG Institute of Medical Research

Dr Richard Nchabi Kamwi, E8 Ambassador


Dr Rose Nani, Malaysia

Dr Rini Poespoprodjo, University of Gadja Mada
  Dr Jeffrey Hii, Malaria Consortium Asia
Vector control at the cross-roads in Asia-Pacific Region: public health entomology & persistent residual malaria transmission

Dr Paola Marchesini, National Malaria Control Program, Ministry of Health, Brazil

Mario Baquilod, Philippines Dr Rob Commons, WWARN
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: an individual patient pooled analysis
  Dr Fredros Okumu, Ifakara Health Institute, Tanzania
Video presentation
Dr Paison Dakulala, Deputy Secretary, Ministry of Health, Papua New Guinea
Perspectives from PNG

Professor Gao Qi, Jiangsu Institute of Parasitic Diseases, China Prof Kevin Baird, Professor of Malariology, Head of Unit, Eijkman Oxford Clinical Research Unit
The dangers of primaquine in patients with G6PD deficiency
  Dr Lorenz von Seidlein,Mahidol University, Thailand Dr Adriana Tami/Dr Maria Grillet, Central University of Venzuala, Caracas
A perspective from Venezuela
Community engagement in malaria elimination: Perspectives from different RSC constituencies on partnering with communities Dr Kamala Ley. Thriemer, Clinical Trials Co-ordinator, Menzies School of Health Research
Safety of low and high dose primaquine
  Dr Larry Slutsker, Director, Center for Malaria Control and Elimination, PATH   Htin Kyaw Thi, Save the Children
Process of optimising the roles of integrated community malaria volunteers in malaria elimination-Myanmar experience
Discussion - Q&A
  Professor Frank Smithuis, Myanmar Oxford Clinical Research Unit
  Jamie Eliades, Population Services International (PSI)
Engaging non-formal private providers in Myanmar to accelerate malaria elimination efforts
 
      Ronaldo Estera, HPA
The role of community based health workers in providing health services to hard to reach populations in the Southern provinces of Laos PDR towards achieving the national goal of eliminating malaria by 2030
 
      Phelele Fakudze, Elimination 8  
      Mr. Prayuth Sudathip, Ministry of Public Health, Thailand  
5:30PM SHORT BREAK

5:45PM POSTER SESSION

6:40PM CONCURRENT 3
  Malaria preventative strategies for Elimination Malaria elimination in the Asia Pacific Region Concurrent Session-Short Talks/Rapid Fire/Pitches/Galleries/Edutainment  
    Chair: Dr Neena Valecha, Director of the ICMR - National Institute of Malaria Research, India    
  Geoff Dow, 60 Degrees Pharmaceuticals LLC
Tafenoquine for malaria prevention
Dr Neena Valecha, Director of the ICMR - National Institute of Malaria Research, India Chika Saito, Malaria No More, Japan
Nikkei Asian conference on communicable diseases: unprecedented innovative public-privateacademia
platform for Japan’s contribution to malaria elimination
 
  Liriye Kurtovic, Burnet Institute
Investigating functional antibody mechanisms against Plasmodium falciparum sporozoites in naturally-acquired and RTS,S vaccine-induced immunity
Dr Vikas Goswami, Godrej Consumer Products Ltd
India: The success of an ecosystem approach to malaria elimination in India
   
  Dr Olusola Oresanya, Malaria Consortium Nigeria
An implementation trial to explore the feasibility, effectiveness, acceptability and cost of a community based system for seasonal malaria prophylaxis (SMC) in selected LGAs in Katsina State, Northern Nigeria
Len Tarivonda, Ministry of Health, Vanuatu
Malaria elimination crossroads in Vanuatu: holding the line as the health sector evolves and vertical funding diminishes
   
  Diego Moroso, Malaria Consortium, Uganda
Prevention at scale: results from a three-year implementation research project expanding access to seasonal malaria chemoprevention in seven Sahelian countries (ACCESS-SMC)
Camilla Burkot, Burnet Institute
Reducing malaria in Solomon Islands: lessons for effective aid
   
  Joaniter Nankabirwa, Makerere University, Uganda      
  Dr Steve Hoffman, CEO Sanaria       
7:30PM DFAT RECEPTION/DINNER